Conference Coverage (ASM)

M. tuberculosis Peptide May Be Vaccine Vehicle

Published in Vaccine Weekly, June 1st, 1998

A small peptide from Mycobacterium tuberculosis, labelled inv3, may be a useful tool for the delivery of macromolecules into mammalian cells, according to a report from the University of California at Berkeley.

"This product of a human pathogen may actually provide many reagents beneficial for human health," researcher Lee Riley said in a presentation to the 98th General Meeting of the American Society for Microbiology, held May 17-21, 1998 in Atlanta, Georgia.

The ability to deliver large molecules into mammalian cells is very important for developing effective vaccines and therapeutic agents. This is because these agents have to go into the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1998-06-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry